Mood effects of the amino acids tryptophan and tyrosine: 'Food for Thought' III Parker and Brotchie Mood effects of amino acids

Acta Psychiatrica Scandinavica

Volumn 124, Issue 6, 2011, Pages 417-426

  Parker, G ^a   Brotchie, H ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Amino acids; Depression; Tryptophan; Tyrosine

Indexed keywords

5 HYDROXYTRYPTOPHAN; CATECHOLAMINE; PLACEBO; SEROTONIN; TRYPTOPHAN; TYROSINE;

ARTICLE; CATECHOLAMINE BLOOD LEVEL; HUMAN; MELANCHOLIA; PRIORITY JOURNAL; SEROTONIN BLOOD LEVEL;

ANTIDEPRESSIVE AGENTS; BIOLOGICAL AVAILABILITY; CATECHOLAMINES; CLINICAL TRIALS AS TOPIC; DEPRESSION; HUMANS; MOOD DISORDERS; NEUROTRANSMITTER AGENTS; NUTRITIONAL REQUIREMENTS; SEROTONIN; SYNAPTIC TRANSMISSION; TRYPTOPHAN; TYROSINE;

EID: 81255141914     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2011.01706.x     Document Type: Article

References (46)

1. Fernstrom JD. Dietary precursors and brain neurotransmitter formation. Ann Rev Med 1981;32:413-425.
2. Meyers S. Use of neurotransmitter precursors for treatment of depression. Altern Med Rev 2000;5:64-71.
3. Young SN, Gauthier AM. Effect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human lumbar and cisternal cerebrospinal fluid. J Neurol Neurosurg Psychiatr 1981;44:323-327.
4. WHO 2007 Available at: (Accessed July 25, 2010).
5. Shaw KA, Turner J, Del Mar C. Tryptophan and 5-hydroxytryptophan for depression (Review). The Cochrane Collaboration. John Wiley and Sons Ltd, 2009.
6. Turner EH, Loftis JM, Blackwell AD. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacol Ther 2006;109:325-338.
7. Owens MJ, Nemeroff CB. Role of serotonin in the physiology of depression: focus on the serotonin transporter. Clin Chem 1994;40:288-295.
8. Coppen A, Eccleston EG, Peet M. Total and free tryptophan concentration in the plasma of depressed patients. Lancet 1973;ii:60-63.
9. Maes M, De Ruyter M, Hobin P, Suy E. Relationship between the dexamethoasone suppression test and the l-tryptophan/competing amino acid ratio in depression. Psychiatr Res 1987;21:323-335.
10. Cowen PJ, Parry-Billings M, Newsholme EA. Decreased plasma tryptophan levels in major depression. J Affect Disord 1989;16:27-31.
11. Moller SE, Kirk L, Honore P. Free and total plasma tryptophan in endogenous depression. J Affect Disord 1979;1:69-76.
12. Anderson IM, Parry-Billings M, Newsholme EA, Poortmans JR, Cowen PJ. Decreased plasma tryptophan concentration in major depression: relationship to melancholia and depression. J Affect Disord 1990;20:185-191.
13. Meltzer HY. Serotonergic dysfunction in depression. Br J Psychiatr 1989;155(Suppl. 8):25-31.
14. Capuron L, Ravaud A, Neveu PJ, Miller AH, Maes M, Dantzer R. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Biol 2002;7:468-473.
15. Moller SE, Kirk L, Honore P. Relationship between plasma ratio of tryptophan to competing amino acids and the response to l-tryptophan treatment in endogenously depressed patients. J Affect Disord 1980;2:47-59.
16. Moller SE, Kirk L. Decreased tryptophan availability in endogenous depression caused by disturbed plasma leucine clearance. Prog Neuro-Psychopharmacol 1981;5:277-279.
17. Coppen A, Shaw DM, Farrell JP. Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan. Lancet 1963;1:79-81. (In E SHORTER. Before Prozac. The troubled history of mood disorders in psychiatry. Ch 8. Losing Ground. Oxford University Press, New York, NY. 2009).
18. Young SN, Leyton M. The role of serotonin in human mood and social interaction. Insight from altered tryptophan levels. Pharmacol Biochem Behav 2002;71:857-865.
19. Van Praag HM, Korf J, Dols LC, Schut T. A pilot study of the predictive value of the probenicid test in application of 5-hydroxytryptophan as antidepressant. Psychopharmacologia 1972;25:14-21.
20. Thomson J, Rankin H, Ashcroft GW et al. The treatment of depression in general practice: a comparison of l-tryptophan, amitriptyline, and a combination of l-tryptophan and amitriptyline with placebo. Psychol Med 1982;12:741-751.
21. Williamson BL, Tomlinson AJ, Hurth KM, Delapas MP, Gleich GJ, Naylor S. Rapid HPLC screening method for contaminants found in implicated l-tryptophan associated with eosinophilia myalgia syndrome and adulterated rapeseed oil associated with toxic oil syndrome. Biomed Chromatogr 1998;12:255-261.
22. Hertzman PA, Blevins WL, Mayer J et al. Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. N Engl J Med 1990;322:869-873.
23. Fernstrom JD. Can nutrient supplements modify brain function? Am J Clin Nutr 2000;71(Suppl.):1669S-1673S.
24. Trucksess MW, Thomas FS, Page SW. High-performance liquid chromatographic determination of 1, 1′-ethylidenebis (l-tryptophan) in l-tryptophan preparations. J Pharm Sci 1994;83:720-722.
25. Markus CR, Firk C, Gerhardt C, Kloek J, Smolders GJF. Effect of different tryptophan sources on amino acids availability to the brain and mood in healthy volunteers. Psychopharmacology 2008;201:107-114.
26. Young SN, Smith SE, Pihl RO, Ervin FR. Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology 1985;87:173-177.
27. Benkelfat C, Ellenbogan M, Dean P, Palmour RM, Young SN. Mood-lowering effect of tryptophan depletion. Arch Gen Psychiatr 1994;51:687-697.
28. Ellenbogen MA, Young SN, Dean P, Palmour RM, Benkelfat C. Mood response to acute tryptophan depletion in healthy volunteers: sex differences and temporal stability. Neuropsychopharmacol 1996;15:465-474.
29. Delgado PL, Charney DS, Price LH, Aghajanian G, Landis H, Heninger GR. Serotonin function and the mechanism of antidepressant action. Arch Gen Psychiatr 1990;47:411-418.
30. Moreno FA, Gelenberg AJ, Heninger GR et al. Tryptophan depletion and depressive vulnerability. Biol Psychiatr 1999;46:498-505.
31. Delgado PL, Miller HL, Salomon RM et al. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine. Biol Psychiatr 1999;46:212-220.
32. O'reardon JP, Chopra MP, Bergan A, Gallop R, Derubeis RJ, Crits-Christoph P. Response to tryptophan depletion in major depression treated with either cognitive therapy or selective serotonin reuptake inhibitor antidepressants. Biol Psychiatr 2004;55:957-959.
33. Ruhé HG, Mason NS, Schene AH. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol Psychiatr 2007;12:331-359.
34. Moreno FA, Heninger GR, Mcgahuey CA, Degrado PL. Tryptophan depletion and risk of depression relapse: a prospective study of tryptophan depletion as a potential predictor of depressive episodes. Biol Psychiatr 2000;48:327-329.
35. Neumeister A, Konstantinidis A, Stastny J et al. Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioural responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatr 2002;59:613-620.
36. 18F] MPPF positron emission tomography study. Biol Psychiatr 2004;56:587-591.
37. Fusar-Poli P, Allen P, Mcguire P, Placentino A, Cortesi M, Perez J. Neuroimaging and electrophysiological studies of the effects of acute tryptophan depletion: a systematic review of the literature. Psychopharmacology 2006;188:131-143.
38. Roisier JP, Levy J, Fromm SJ et al. The effects of tryptophan depletion on neural responses to emotional words in remitted depression. Biol Psychiatr 2009;66:441-450.
39. Gibson CJ, Wurtman RJ. Physiological control of brain norepinephrine synthesis by brain tyrosine concentration. Life Sci 1978;22:1399-1406.
40. Benkert O, Renz A, Marano C, Matussek N. Altered tyrosine daytime plasma levels in endogenous depressive patients. Arch Gen Psychiatr 1971;25:359-363.
41. Gelenberg AJ, Wojcik JD, Growdon JH, Sved AF, Wurtman RJ. Tyrosine for the treatment of depression. Am J Psychiatr 1980;137:622-623.
42. Goldberg IK. l-tyrosine in depression. Lancet 1980;2:364-365.
43. Gelenberg AJ, Wojcik JD, Gibson CJ, Wurtman RJ. Tyrosine for depression. J Psychiatr Res 1983;17:175-180.
44. Gelenberg AJ, Wojcik JD, Falk WE et al. Tyrosine for depression: a double-blind trial. J Affect Disord 1990;19:125-132.
45. Hegarty BD, Parker G. Marine omega-3 fatty acids and mood disorders - linking the sea and the soul. 'Food for Thought' I. Acta Psychiatr Scand 2011;124:42-51.
46. Parker G, Brotchie HL. 'D' for depression: any role for Vitamin D? 'Food for Thought' II. Acta Psychiatr Scand 2011;124:243-249.